Ocular hypertension has been reported in 0–3.5% of cases (1,5)[C].
REFERENCES
1.Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43–50.
2.Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Fam Physician. 2010;81(2):137–144.
3.Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835–854.
4.Kirkwood BJ, Kirkwood RA. Episcleritis and scleritis. Insight. 2010;35(4):5– 8.
5.Berchicci L, Miserocchi E, Di Nicola M, et al. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Eur J Ophthalmol. 2014;24(3):293–298.
6.Williams CP, Browning AC, Sleep TJ, et al. Arandomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. Eye (Lond). 2005;19(7):739–742.
ADDITIONALREADING
Daniel Diaz J, Sobol EK, Gritz DC. Treatment and management of scleral disorders. Surv Ophthalmol. 2016;61(6):702–717.
CODES
ICD10
H15.109 Unspecified episcleritis, unspecified eye
H15.129 Nodular episcleritis, unspecified eye
H15.102 Unspecified episcleritis, left eye
CLINICALPEARLS
Episcleritis typically is a benign, self-limited disorder.
Often not painful and presents without decrease in visual acuity
Although treatment is often not needed, when employed, the goal is